편집
13,127
번
새 문서: Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration : PIER Study Year 1 (PIER) " == 목적 == 나이 관련 황반 변...
(새 문서: Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration : PIER Study Year 1 (PIER) " == 목적 == 나이 관련 황반 변...) |
(차이 없음)
|